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Aipha-adrenoceptors and angiotensinogen gene expression in
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Aipha-adrenoceptors and angiotensinogen gene expression in opossum
kidney cells. To investigate whether alpha (n)-adrenoceptor agonists have
a stimulatory effect on the expression of the angiotensinogen (Ang) gene
in opossum kidney (OK) cells, we used OK 27 cells with a fusion gene
containing the 5-flanking regulatory sequence of the rat angiotensinogen
gene fused with a human growth hormone (hGH) gene as a reporter,
pOGH (Ang N-1498/+ 18), permanently integrated into their genomes.
The level of expression of the pOGH (Ang N-1498/+ 18) was quantitated
by the amount of immunoreactive-human growth hormone (IR-hGH)
secreted into the medium. The addition of iodoclonidine (n2-adrenocep-
tor agonist, i0 to i0 M) and phorbol 12-myristate 13-acetate (PMA,
i0 to i0 M) stimulated the expression of pOGH (Ang N-1498/+18)
in a dose-dependent manner, whereas the addition of phenylephrine
(a1-adrenoceptor agonist, i0 to i0 M) had no effect. The stimulatoiy
effect of iodoclonidine was blocked by the presence of yohimbine (a2-
adrenoceptor antagonist) and staurosporine (an inhibitor of protein
kinase C) but not blocked by the presence of prazosin (a1-adrenoceptor
antagonist) or Rp-cAMP (an inhibitor of cAMP-dependent protein kinase
A). The addition of iodoclonidine, phenylephrine or PMA had no effect
on the expression of pTKGH in OK 13 cells, an OK cell line, into which
had been stably integrated a fusion gene, pTKGH containing the promot-
er/enhancer DNA sequence of the viral thymidine-kinase (TK) gene fused
with a human growth hormone gene as a reporter. These studies demon-
strated that the expression of the pOGH (Ang N-1498/+ 18) in OK 27 cells
is stimulated by a2-adrenoceptors and the protein kinase C pathway. Our
data indicate that OK 27 cells provide a useful model to study the
regulation of the expression of the Ang gene in vitro.
The existence of a local intrarenal renin-angiotensin system
(RAS) has now been generally accepted [1, 2]. Evidence indicated
that angiotensinogen (Ang) mRNA and renin mRNA are present
in the rat renal proximal tubules [3—5]. Measurement of angio-
tensin levels in the lumen of rat proximal tubules showed that the
concentration of angiotensin I (Ang I) or angiotensin II (Ang II)
is as high as i0 M, whereas the level of plasma Ang I or Ang II
is less than 1012 M [6—8]. Moreover, recent studies also showed
that the levels of urinary angiotensins are independent of plasma
angiotensin levels [9]. Thus, these studies demonstrated that the
renal proximal tubule is a major site of intrarenal Ang formation.
We [10], as well as Ingelfinger eta! [11], have demonstrated that
the Ang mRNA is expressed in opossum kidney (OK) cells. We
have also reported that dexamethasone and 8-bromo-cyclic aden-
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osine monophosphate (8-Br-cAMP) stimulate the expression of
the Ang gene in OK cells [12]. More recently, we have reported
that the addition of isoproterenol stimulates the expression of the
Ang gene and increases the accumulation of intracellular cAMP
in OK 27 cells, an OK cell line into which has been stably
integrated a fusion gene, pUGH (Ang N-14981+ 18), containing
the endogeneous 5'-flanking regulatory DNA sequence of the rat
Ang gene fused with a human growth hormone (hGH) gene as a
reporter [13]. These studies raise the possibility that the increase
of intracellular cAMP, which is induced by the stimulation of
p-adrenoceptors (that is, via the activation of renal nerves), may
enhance the expression of the renal Ang gene. The local forma-
tion of renal Ang II might then modulate the physiology of the
renal proximal tubular cells (that is, sodium and fluid absorption)
[14—16]. Thus, local renal RAS might play an important role in
the modulation of sodium reabsorption.
Alpha-adrenoceptors have been detected on the proximal tu-
bules of rat kidney with the dominance of the ct2-adrenoceptors
[17—20]. It is estimated that the amount of a2-adrenoceptors is
over twofold greater than a1-adrenoceptors in the rat proximal
tubules [211. Studies have shown that renal nerves, acting through
a-adrenoceptors enhance proximal tubular sodium reabsorption
(anti-natriuresis) in the kidney [20, 22]. Alpha-adrenoceptors are
also expressed in OK cells [23, 24]. OK cells express an a2-
adrenoceptor which has pharmacological characteristics different
from both the a2A and a2B subtypes. It has been tentatively named
a2c subtype [241, and this subtype is negatively coupled to
adenylate cyclase. The presence of a2-adrenoceptor subtypes
raises the question of whether the activation of this receptor
subtype could inhibit or modulate the expression of the Ang gene
in OK cells.
Thus, in the present studies, we investigated the possible effect
of alpha (a)-adrenoceptor agonists on the expression of the Ang
gene in OK 27 cells. We also examined whether the addition of
phorbol 12-myristate 13-acetate (PMA, a protein kinase C stim-
ulator) has an effect on the expression of the pOGH (Ang
N-1498/+ 18) in OK 27 cells. Our results indicated that the
expression of pOGH (Ang N-1498/+ 18) fusion gene in OK 27
cells is stimulated by the addition of iodoclonidine (a2-adreno-
ceptor agonist) and PMA, but not by the addition of phenyleph-
rine (a1-adrenoceptor agonist). Furthermore, the addition of
yohimbine (a2-adrenoceptor antagonist) and staurosporine (an
inhibitor of protein kinase C) blocked the stimulatory effect of
iodoclonidine.
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Methods
Materials
The fusion gene, pOGH (Ang N-1498/+18), containing the
5'-flanking sequence [1498 base-pair (bp)] upstream of the tran-
scriptional site plus 18 bp of Exon I of the rat Ang gene fused with
a hGH gene, has been described previously [25]. The plasmid,
pRSV-Neo, containing the coding sequence for Neomycin (Neo)
with the Rous sarcoma virus (RSV) enhancer/promoter sequence
fused into the 5'-end of the Neomycin gene was a gift from Dr.
Teresa Wang (Dept. of Pathology, Stanford University, Stanford,
CA, USA). The plasmid, pTKGH, containing the thymidine
kinase (TK) enhancer/promoter sequence fused to the 5'-end of
the hGH gene was purchased from the Nichols Institute of
Diagnostics (La Jolla, CA, USA).
The radioimmunoassay kit for hGH (RIA-hGH) was a gift from
NIADDK (NIH, Bethesda, MD, USA). The double antibody RIA
procedure was similar to that previously used for the radioimmu-
noassay of ovine placental lactogen (RIA-0PL) [26]. Human
[1251]iodo GH was prepared by a slight modification of the
lactoperoxidase method of Thorell and Johannson [27].
NIAMDD-hGH-I-1 (AFP-4793 B) was used for both iodination
and as a hormone standard. The limit of sensitivity of the assay
was 0.1 ng/ml. The inter- and intra-assay coefficients of variation
were 10% (N = 10) and 12% (N = 10), respectively.
P-iodoclonidine hydrochloride (a2-adrenoceptor agonist), phe-
nylephrine hydrochloride (a1-adrenoceptor agonist), yohimbine
hydrochloride (a2-adrenoceptor antagonist), prazosin hydrochlo-
ride (a1-adrenoceptor antagonist), staurosporine (an inhibitor of
protein kinase C), phorbol 12-myristate 13-acetate (PMA; a
stimulator of protein kinase C) and Rp-cAMP (an inhibitor of
cAMP-dependent protein kinase A I & II) were all purchased
from Research Biochemicals Inc. (RBI, Natick, MA, USA).
Na-1251 was purchased from Dupont, New England Nuclear
(NEN; Boston, MA, USA). Calcium chloride was purchased from
Mallinckrodt, Inc. (Montreal, Quebec, Canada), Geneticin (U
418) was purchased from Bethesda Research Laboratories
(Gibco-BRL, Burlington, Ontario, Canada). Other molecular
biology grade reagents were obtained either from Sigma Chemi-
cals (St. Louis, MO, USA), Gibco-BRL, Boehringer-Mannheim
(Dorval, Quebec, Canada), Pharmacia Inc. (Baie d'Urfe, Quebec,
Canada) or Promega-Fisher, Inc. (Montreal, Quebec, Canada).
Cell culture
The opossum kidney (OK) proximal tubular cell line was
obtained from the American Type Tissue Culture Collection
(ATCC) (Rockville, MD, USA). This cell line is derived from the
kidney of a female American opossum which retains several
properties of proximal tubular epithelial cells in culture and
expresses a low level of Ang mRNA [10, 28, 29].
The cells were initially grown in 100 X 20 mm plastic Petri
dishes (Gibco) in Dulbecco's Modified Eagle's Medium
(DMEM), pH 7.45, supplemented with 10% fetal bovine serum
(FBS), 50 U/ml penicillin and 50 xg/ml streptomycin. The cells
were grown in a humidified atmosphere of 95% 02, 5% CO2 at
37°C. For subculturing, the cells were trypsinized (0.05% trypsin
and EDTA) and plated at 2.5 X i0 cells/dish (100 X 20 mm).
OK cell stable transformants
The method for the selection of OK cell stable transformants
with high expression of pOGH (Ang N-1498/+ 18) (OK 27) or
pTKGH (OK 13) has been described previously [13]. Briefly,
plasmids pOGH (Ang N-1498/+18) or pTKGH and pRSV-Neo
fusion genes were co-transfected (20 jxg each) into OK cells (1 x
106 cells) utilizing calcium phosphate-mediated endocytosis. After
transfection, the cells were cultured overnight in 5.0 ml of DMEM
containing 10% FBS. Then the medium was replaced with fresh
medium containing 10% FBS and 500 xg/ml of aminoglycoside G
418 (Geneticin, Gibco Inc.). The stable transformants which were
able to grow in the presence of G418 and which secreted high
levels of IR-hGH into the medium were further subcloned using
the method of limiting dilution. Those cells that had passed
through at least three repetitions of limiting dilution and contin-
ued to secrete high levels of IR-hGH after three months in the
presence of G 418 were considered to be stable clones. We have
obtained three and six clones with pOGH (Ang N-1498/+18) and
pTKGH integrated into their genomes, respectively. In the
present study, we used two of these clones, clone OK 27 and OK
13 which have pOGH (Ang N-1498/+18) and pTKGH integrated
into their genomes, respectively.
Effect of iodoclonidine or phenylephrine or phorbol 12-myristate
13-acetate (PM4) on the expression of pOGJ-I (Ang N-1498/+18)
in OK 27 cells
OK 27 cells were plated at a density of 1 to 2 x i0 cells/well in
six-well plates and incubated overnight in DMEM containing 10%
FBS. The growth of the cells was arrested by the incubation in
serum-free DMEM for 24 hours. Subsequently, various concen-
trations of iodoclonidine (10—13 to iO M) or phenylephrine
(1013 to iO M) or PMA (10—' to iO M) were added to the
culture medium containing 1% dFBS and incubated for 24 hours.
The depleted FBS was prepared by incubation with 1% acti-
vated charcoal and 1% analytical grade (AG I X 8) ion exchange
resin (Bio-Rad Laboratories, Richmond, CA, USA) for 16 hours
or more at room temperature as described by Samuels, Stanley
and Shapiro [30]. This procedure removed endogenous steroid
and thyroid hormones from the FBS, as demonstrated [30].
Effect of yohimbine or prazosin or staurosporine or Rp-cAMP on
the expression of pOGH (Ang N-1498/+18) in OK 27 cells in the
presence of iodoclonidine
OK 27 cells were plated at a density of 1 to 2 x i0 cells/well in
six-well plates and incubated overnight in DMEM containing 1%
dFBS. Then cell growth was arrested by incubation in serum-free
medium for 24 hours. Various concentrations of yohimbine
(1013 to iO M) or prazosin (10— 13 to iO M) or staurosporine
(10— 13 to 10 M) or Rp-cAMP (10's to iO M) were added to
the culture medium and co-cultured with the iodoclonidine (10—p
M) for 24 hours. At the end of the incubation period, media were
collected and kept at —20°C until assay for IR-hGH.
Effect of staurosporine on the expression of pOGH (Ang N-1498/
+ 18) in OK 27 cells in the presence of PMA
OK 27 cells were plated at a density of ito 2 X io cells/well in
six-well plates and incubated overnight in DMEM containing 1%
dFBS. Cell growth was arrested by incubation in serum-free
medium for 24 hours. Then various concentrations of staurospo-
rine (10_13 to iO M) were added to the culture medium and
co-cultured with the PMA (10 M) for 24 hours. At the end of the
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Fig. 1. Effect of iodoclonidine and phenylephrine on the expression of
pOGH(AngN-1498/+18) in OK27celLc. Cells were incubated for up to 24
hours in the presence of various concentrations of iodoclonidine or
phenylephrine. Media were harvested after 24 hours of incubation and
assayed for immunoreactive human growth hormone (IR-hGH). The
concentration of IR-hGH in the absence of iodoclonidine or phenyleph-
rifle is considered as the control level. Each point represents the mean
SD of at least three dishes (°P 0.05,  0.01 and ***  0.005).
Symbols are: (• iodoclonidine; 0 phenylephrine).
incubation period, media were collected and kept at —20°C until
assay for IR-hGH.
Effect of iodoclonidine or phenylephrine or PMA on the expression
of pTKGH in OK 13 cells
OK 13 cells were plated at a density of I to 2 X i0 cells/well in
six-well plates and incubated overnight in DMEM containing 1%
dFBS. Cell growth was arrested by incubation in serum-free
medium for 24 hours. Subsequently, iodoclonidine (10—v M) or
phenylephrine (10° M) or PMA (10 M) was added to the
culture medium containing 1% dFBS and incubated for 16 hours.
At the end of the incubation period, media were collected and
kept at —20°C until assay.
Statistical analysis
The experiments were performed at least three times in tripli-
cate. The data were analyzed with Student's t-test or ANOVA
analysis. A probability level of P  0.05 was regarded as signifi-
cant.
Results
Effect of iodoclonidine or phenylephrine or PMA on the expression
of pOGH (Ang N-1498/+18) in OK 27 cells
Figure 1 shows the expression of the pUGH (Ang N-1498/+18)
in OK 27 cells in the presence of various concentrations of
iodoclonidine (10— 13 to 10 M). A dose-dependent relationship
between iodoclonidine concentrations (10-- 13 to i0 M) and the
stimulation of expression of pOGH (Ang N-1498/+ 18) was ob-
served. It appears that maximal stimulation of expression of the
pOGH (Ang N-1498/+18) was found with 10 'M iodoclonidine.
At concentrations greater than iO M, the stimulatory effect of
iodoclonidine is diminished. The addition of phenylephrine
(10— 13 to i0 M) had no stimulatory effect on the expression of
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Fig. 2. Effect of phorbol 12-myristate 13-acetate (PMA) on the expression of
pOGH (Ang !'.J-1498/+18) in OK27cells. Cells were incubated for up to 24
hours in the presence of various concentrations of PMA. Media were
harvested after 24 hours of incubation and assayed for IR-hGH. The
concentration of IR-hGH in the absence of PMA is considered as the
control level. Each point represents the mean SD of at least three dishes
(°P 0.05, **p 0.01 and *** 0.005).
the pUGH (Ang N-14981+18) in OK 27 cells, as shown in Figure
A dose-dependent relationship between PMA concentrations
(10—13 to i0 M) and the stimulation of expression of pUGH
(Ang N-1498/+18) was also observed as shown in Figure 2. The
effective and maximal stimulation of expression of the pUGH
(Ang N-1498/+18) were found with 10— M (P 0.01) and i05
M (P 0.001) PMA. At concentrations greater than iO M PMA,
lesser amounts of IR-hGH were measured (unpublished results).
This observation was due to an increased cell death in the culture.
These studies suggest that the stimulatory effect of a-adreno-
ceptors on the expression of pOGH (Ang N-1498/+ 18) in OK 27
cells is probably mediated via the cw2-adrenoceptors and protein
kinase C pathway.
Effect of yohimbine or prazosin or staurosporine or Rp-cAMP on
the expression of pOGH (Ang N-1498/+ 18) in OK 27 cells in the
presence of iodoclonidine
Figure 3 shows that the addition of yohimbine (10—' to i0 M)
inhibited the stimulatory effect of iodoclonidine (10 M) on the
expression of the pOGH (Ang N-1498/+18) in OK 27 cells. The
effective dose for inhibition of the stimulated expression (by
iodoclonidine) of the pUGH (Ang N-1498/+18) was i0 M
yohimbine (P  0.05). The addition of prazosin (10—13 to iO M)
had no inhibitory effect on the expression of pOGH (Ang
N-1498/+18) stimulated by iodoclonidine (10 M).
Similarly, the addition of staurosporine (10's to iO M)
inhibited the stimulatory effect of iodoclonidine (10° M) on the
expression of the pUGH (Ang N-14981+18) in OK 27 cells in a
dose-dependent manner (Fig. 4). The effective dose for the
inhibition of the stimulated expression (by iodoclonidine) of the
pUGH (Ang N-1498/+18) was 10— M staurosporine (P  0.05;
Fig. 4). The addition of staurosporine (10_13 to iO M) alone had
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Fig. 3. Inhibitoiy effect of yohimbine (a2-adrenoceptor antagonist) or pTa-
zosin (a1-adrenoceptor antagonist) on the expression of pOGH (AngN-1498/
+18) in OK 27 cells stimulated by iodoclonidine. The cells were incubated
for up to 24 hours in the presence of iodoclonidine (10—p M) and various
concentrations of yohimbine (10—' to i0 M) or prazosin (10—13 to i0
M). Media were harvested and assayed for the level of IR-hGH. The
concentration of IR-hGH in the absence of yohimbine or prazosin is
considered as the control level. Each point represents the mean so of at
least three dishes (*P  0.05, 0.01 and *** 0.005). Symbols are:
(S yohimbine; 0 prazosin).
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Fig. 4. Inhibitoiy effect of staurosporine or Rp-cAMP on the expression of
pOGH (Ang N-14981+18) in OK 27 cells stimulated by iodoclonidine. Cells
were incubated for up to 24 hours in the presence of iodoclonidine (10
M) and various concentrations of staurosporine (10_13 to i0 M) or
Rp-cAMP (10—13 to iO M). Media were harvested and assayed for the
level of IR-hGH. The concentration of IR-hGH in the presence of
iodoclonidine (l0- M) but in the absence of staurosporine or Rp-cAMP
is the control level. Each point represents the mean SD of at least three
dishes (*P 0.05, **p 0.01 and *** 0.005). Symbols are: (S
staurosporine; 0 Rp-cAMP).
no significant effect on the expression of pOGH (Ang N-1498/
+ 18) in OK 27 cells (unpublished data). On the other hand, the
addition of Rp-cAMP (10— 13 to i0 M) had no inhibitory effect
on the expression of pOGH (Ang N-1498/+ 18) stimulated by
iodoclonidine (10—p M; Fig. 4).
Figure 5 illustrates that the addition of staurosporine (1013 to
Concentration, molarity
Fig. 5. Effect of staurosporine on the expression of pOGH (Ang N-14981
+18) in OK 27 cells stimulated by PMA. Cells were incubated for up to 24
hours in the presence of PMA (10—v M) and various concentrations of
staurosporine (10— 13 to iO M). Media were harvested and assayed for
the level of IR-hGI-T. The concentration of IR-hGH in the presence of
PMA (10 M) but in the absence of staurosporine is the control level.
Each point represents the mean SD of at least three dishes (*P 0.05,
**p  0.01 and *** 0.005).
io M) inhibited the stimulatory effect of PMA (10 M) on the
expression of the pOGH (Ang N-1498/+ 18) in OK 27 cells in a
dose-dependent manner. The effective dose for the inhibition of
the stimulated expression (by PMA) of the pOGH (Ang N-1498/
+18) was io' M staurosporine (P  0.05).
These studies further support the notion that activation of
cs2-adrenoceptors stimulate the expression of the fusion gene via
the protein kinase C pathway, but not via the cAMP-dependent
protein kinase A pathway.
Effect of iodoclonidine or phenylephrine or PMA on the expression
of pTKGH in OK 13 cells
In OK 13 cells, neither iodoclonidine (10—v M), phenylephrine
(10 M) nor PMA (10 M) stimulated the expression of pTKGH
as compared to the controls (absence of iodoclonidine, phe-
nylephrine or PMA; Fig. 6).
Discussion
Clones OK 27 and OK 13 are stable transformants with pOGH
(Ang N-1498/+18) and pTKGH integrated into OK cellular
genomes, respectively. The characteristics of these clones have
been reported previously [13]. Briefly, the expression of pOGH
(Ang N-1498/+18) and pTKGH in OK 27 and OK 13 cells,
respectively, were time-dependent. The levels of IR-hGH in
cellular extracts were consistently less than 5% of that found in
the culture media, suggesting that renal Ang, like hepatic Ang
[31], is not stored in the cell.
Renal nerves are known to influence sodium and fluid transport
by the kidney [32—34]. The mechanism(s) whereby renal nerves
exert their effects, however, is not well understood. Recent studies
by Nakamura and Johns [35] demonstrated that low levels of renal
nerve stimulation decrease sodium excretion and increase the
levels of the Ang mRNA in the rat kidney in vivo, but not renin
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Fig. 6. Effect of iodoclonidine, phenylephrine and PMA on the expression of
pTKGH in OK 13 cells. Cells were incubated for 24 hours in the absence
or presence of iodoclonidine (10—p M) or phenylephrine (10- M) or PMA
(i0 M). Media were harvested 24 hours after the incubation and assayed
for IR-hGH. Each point represents the mean SD of a minimum of three
dishes. The concentration of IR-hGH in the absence of iodoclonidine,
phenylephrine and PMA is the control level. The empty bar on the
extreme left is without added hormones. The second striped bar is from
iodoclonidine treated cells, the third hatched bar is from phenylephrine
treated cells and the solid black bar on the extreme right is from PMA(10 M) treated cells (*P  0.05,  0.01 and *** 0.005).
mRNA. In contrast, high levels of renal nerve stimulation increase
the level of renin mRNA, but not Ang mRNA. Furthermore, the
administration of the 31-adrenoceptor antagonist, atenolol,
blocked the effect of renal nerve stimulation. This observation is
supported by our recent studies that isoproterenol directly stim-
ulates the expression on the Ang gene in OK cells in vitro [13]. The
stimulatory effect of isoproterenol is blocked by the presence of
propranolol and the /31-adrenoceptor antagonist, atenolol [131.
Thus, these studies indicate that the stimulation of renal nerve
could activate the intrarenal renin-angiotensin system (RAS) by
stimulating the expression of the Ang gene in the kidney in vivo.
The intrarenal Ang II formation may then modulate the reabsorp-
tion of sodium and fluids in the proximal tubules.
OK cells express a2-adrenoceptor which is negatively coupled
to adenylate cyclase [24]. The inhibitory effect of a2-adrenocep-
tor on cAMP production in OK cells raises the possibility that
a2-adrenoceptor might also attenuate the expression of the Ang
gene. We are surprised that the c2-adrenoceptor agonist, iodo-
clonidine, stimulates the expression of the pOGI-I (Ang N-I 498!
+18) in OK 27 cells (Fig. 1). These results confirm the studies of
Murphy and Bylund [23] and Blaxall et al [24], who reported the
presence of a2-adrenoceptors. At present, we do not understand
why higher concentrations of iodoclonidine (that is, greater than
iO M) have lower stimulatory effects on the expression of the
pOGH (Ang N-14981+ 18) in OK 27 cells. One possible explana-
tion may be that the exposure of OK cells to high levels of
a2-adrenoceptor agonists may desensitize their own adrenocep-
tors. Indeed, this possibility is supported by the observations of
Kurose and Lefkowitz [36] that cs-adrenoceptors are subject to
desensitization by their own agonists. Nevertheless, more experi-
ments are warranted to clarify these observations. We did not
observe any significant stimulation of the pOGH (Ang N-1498/
+ 18) by phenylephrine (a1-adrenoceptor agonist) in OK 27 cells
(Fig. 1). This might be explained by the fact that there is a low or
undetectable amount of a1-adrenoceptor in OK cells, as demon-
strated by the binding studies of Murphy and Bylund [23].
Up until now, there is no report to indicate that the activation
of a2-adrenoceptor is coupled to PKC pathway in OK cells.
Studies by Cotecchia et al [37], however, demonstrated that the
stimulation of a2-C10 and a2-C4 adrenoceptors inhibits and
activates the adenylate cyclase and phospholipase C activity in
eukaryotic cells, respectively. Thus, these studies suggest that
there are multiple second messenger pathways (such as PKA and
PKC) for cs-adrenergic receptors. Our present studies showed that
PMA stimulates the expression of the pUGH (Ang N-1498/+ 18)
in a dose-dependent manner (Fig. 2). Since PMA is a potent
stimulator of protein kinase C [38], these studies confirm the
presence of PKC in OK cells [39, 40] and raise the possibility that
the route of iodoclonidine, in exerting its effect, is mediated via
the protein kinase C pathway. Indeed, our results showed that
yohimbine (Fig. 3) and staurosporine (a potent inhibitor of
protein kinase C [41]) (Fig. 4) inhibit the expression of the pOGH
(Ang N-1498/+ 18) stimulated by iodoclonidine in OK 27 cells in
a dose-dependent manner. These data further support the hy-
pothesis that the effect of a2-adrenoceptors on the expression of
the Ang gene is probably via the protein kinase C pathway and not
via the protein kinase A pathway, since Rp-cAMP (an inhibitor of
cAMP-dependent protein kinase A [42]) did not inhibit the effect
of iodoclonidine on the expression of the pUGH (Ang N-1498/
+18) in OK 27 cells (Fig. 4).
Furthermore, our studies showed that the addition of stauro-
sporine blocks the effect of PMA on the expression of pOGH
(Ang N-1498/+18) in OK 27 cells (Fig. 5). These data further
confirm that protein kinase C is involved in the expression of the
Ang gene in OK cells.
Prazosin has a Ki which is approximately 80-fold less potent
than yohimbine in competition for the displacement of 3H-
rauwolscine in OK cell membrane preparation [24]. At present,
we do not understand why prazosin at concentrations as high as
i0 M does not inhibit the stimulatory effect of iodoclonidine
(Fig. 4). One possible explanation may be that the discrepancy is
due to different methods employed in the studies of Blaxall et al
[24], who used OK cellular membranes for binding studies,
whereas we employed intact OK cells for studies in gene expres-
sion. The second possibility may be due to the source of OK cells
used in our studies and in the studies of Blaxall et a! [24]. Since
our OK 27 cell is a subclone and derived from a heterogenous
population (obtained from ATCC), it is possible that OK 27 cells
may be different (at the receptor level) from OK cells used in the
studies of Blaxall et al [24]. Nevertheless, more studies are
necessary to clarify this discrepancy.
The OK 13 cell is a cell line into which has been stably
integrated a fusion gene: pTKGH containing the promoter!
enhancer DNA sequence of the viral thymidine kinase gene fused
with a human growth hormone gene as a reporter. The expression
of the pTKGH in OK 13 cells is driven by the promoter/enhancer
DNA sequence of the thymidine kinase (TK) gene. Therefore, we
used OK 13 cells as control cells to examine the effect of
adrenoceptor agonists. We did not observe any significant stimu-
lation of expression of the pTKGH by neither iodoclonidine (10
M), phenylephrine (10 M) nor PMA (10 M) in OK 13 cells
lodoclonidine Phenylephrine PMA
1O 1O 10
Concentration, molarity
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(Fig. 6). These data demonstrate that the promoter/enhancer
DNA sequence of TK gene is not responsive to the addition of
iodoclonidine, phenylephrine nor PMA. On the other hand, our
studies demonstrated that the effect of iodoclonidine and PMA on
the expression of pOGH (Ang N-1498/+ 18) in OK 27 cells is
gene-specific and mediates via the 5'-flanking regulatory se-
quences of the rat Aug gene and not mediated via the DNA
sequence of the hGH reporter gene.
At present, we do not understand the molecular mechanism(s)
of protein kinase C on the expression of the Ang-GH fusion gene.
Our previous studies [25], however, have shown that there is DNA
sequence (nucleotides N-758 to N-752, TGACTAC) in the 5'-
flanking regulatory sequence of the rat Ang gene which is almost
identical to the consensus AP-1 sequence (TGACTCA) [43], with
the exception that the last two nucleotides are in reverse order.
This raises the possibility that the activation of protein kinase C
might induce the expression of early-immediate protooncogenes,
that is, c-Fos and c-Jun genes. These protooncogenes form an
heterodimer complex (AP-1 complex) and then bind to the
putative AP-1 DNA sequence (Aug N-758 to N-752). Subse-
quently, the AP-1 complex enhances the expression of the Ang
gene. Indeed, more studies are warranted to investigate this
possibility.
Another possibility may be that the activation of protein kinase
C phosphorylates the cAMP-responsive element binding protein
(CREB) or CREB-like nuclear protein(s), since CREB contains
the site of phosphorylation by protein kinase C [44]. The phos-
phorylated CREB then binds with the putative cAMP-responsive
element (CRE) of the rat Aug gene (TGACGTAC, nucleotides
N-795 to N-788) [25] and subsequently enhances the expression of
the Ang gene. This possibility is supported by our preliminary
studies that the cloned CREB is able to stimulate directly the
expression of the pOGH (Ang N-1498/+18) in OK 27 cells
(unpublished results). Nevertheless, more studies are warranted
to elucidate the molecular mechanism(s) of protein kinase C
activation and the expression of the Ang gene in OK cells.
It is intriguing that both f3-adrenoceptor agonist (isoproterenol)
[13] and iodoclonidine stimulate the expression of pOGH (Aug
N-1498/+18) in OK 27 cells. Since a2-adrenoceptor is known to
uncouple the adenylate cyclase system [23] in OK cells, this raises
the question of whether cs2-adrenoceptor could modulate the
effect of /3-adrenoceptors on the expression of Ang gene or vice
versa. Indeed, studies are underway in our laboratory to investi-
gate this possibility.
In summary, our studies show that the addition of iodoclonidine
directly stimulates the expression of the Ang-GH fusion gene in
OK 27 cells. Furthermore, the stimulatory effect of iodoclonidine
could be blocked by the presence of yohimbine and staurosporine.
These studies demonstrate that there are putative transactivating
factors in OK cells which interact with the 5'-flanking sequence of
the Ang gene to promote its expression. The effect of a2-
adrenoceptors on the expression of the renal Aug gene may be
mediated via the protein kinase C pathway. Our studies indicate
that the activation of renal nerves may stimulate the expression of
the renal Aug gene via a2-adrenoceptors in vivo. The local
formation of renal All might then modulate the physiology of the
renal proximal tubular cells (that is, sodium and fluid absorption).
Thus, local renal RAS might play a significant role in the
modulation of sodium reabsorption.
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